Korean Drug Co., Ltd. announces an Equity Buyback for 20,000 shares.
December 10, 2018
Share
Korean Drug Co. Ltd. (KOSE:A014570) announces a share repurchase program. Under the program, the company will repurchase up to 20,000. The purpose of the share repurchase program is to raise stock value through stability of stock price and payment of retiree incentives. The share repurchase program is valid till March 11, 2019. As of December 11, 2018, the company had 86,020 shares in treasury within scope available for dividend and had no shares in treasury through other repurchase.
KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.
KOREAN DRUG CO., LTD. 
